419 filings
Page 5 of 21
DEFA14A
4q2on6wgy
29 Mar 21
Additional proxy soliciting materials
5:20pm
DEFA14A
w57sfiiz
26 Mar 21
Additional proxy soliciting materials
9:43pm
DEFA14A
0bvtgd8udghckgkw
11 Mar 21
Additional proxy soliciting materials
5:25pm
8-K
ctm5 fqur8
11 Mar 21
Onconova Therapeutics Reports Full Year 2020 Financial Results, Provides Business Update
4:33pm
DEFA14A
0hothzewpmd513g97h1
8 Mar 21
Additional proxy soliciting materials
5:20pm
DEFA14A
2svwfaublr9n2m4kz
4 Mar 21
Additional proxy soliciting materials
4:55pm
8-K/A
wkjbs9pj w1
4 Mar 21
Submission of Matters to a Vote of Security Holders
4:52pm
8-K
4brxd vl3x4xw
4 Mar 21
Submission of Matters to a Vote of Security Holders
9:21am
DEFA14A
gsb3iws0k7uaioopkss
26 Feb 21
Additional proxy soliciting materials
5:20pm
8-K
ekhnc egthh
24 Feb 21
Other Events
8:05am
8-K
i74c6co07 msmva91c
19 Feb 21
Departure of Directors or Certain Officers
5:19pm
DEFA14A
1kjqp68 vswey8o
19 Feb 21
Additional proxy soliciting materials
5:18pm
8-K
5kzvl66tfhx
16 Feb 21
Onconova Therapeutics, Inc. Announces Closing of $28.75 Million Public Offering of Common Stock Including Full Exercise of the Over-Allotment Option
4:08pm
8-K
eddqd fospjpe2z
12 Feb 21
Onconova Therapeutics, Inc. Announces Pricing of $25 Million Public Offering of Common Stock
12:00am
424B5
wzwt9
11 Feb 21
Prospectus supplement for primary offering
5:30pm
424B5
2dmr719 24ai
10 Feb 21
Prospectus supplement for primary offering
4:35pm
DEFA14A
pbe5t7gpod9
3 Feb 21
Additional proxy soliciting materials
5:15pm
8-K
ys65oqs
15 Jan 21
Departure of Directors or Certain Officers
5:15pm